PROKIDNEY CORP. (PROK)
About PROKIDNEY CORP.
ProKidney Corp is a clinical-stage biotechnology company pioneering the development of a first-in-class, autologous cell therapy that is intended to preserve kidney function in patients with advance chronic kidney disease (CKD) and diabetes. Its product candidate, REACT (Renal Autologous Cell Therapy), is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Net income
- -$69.0M
- Total assets
- $335.6M
- Market cap
- $369.4M
- Operating margin
- -18477.8%
- Net margin
- -16977.8%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $893.0K
- Operating expenses
- $165.9M
- Operating income
- -$165.0M
- Income tax
- $414.0K
- Net income
- -$151.6M
Balance sheet
- Total assets
- $335.6M
- Current assets
- $280.7M
- Total liabilities
- $34.8M
- Current liabilities
- $30.7M
- Shareholders’ equity
- -$1.0B
Cash flow
- Operating cash flow
- -$120.1M
- Investing cash flow
- $104.0M
- Financing cash flow
- $25.6M
- Net cash flow
- $9.4M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $369.4M
- Shares outstanding
- 246.2M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jul 12, 2022
Prokidney Corp. (PROK) Stock Price
- Reported a net loss of $69.0M.
- Trading 71% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review PROKIDNEY CORP..
Write a review
News about PROKIDNEY CORP.
News & sentiment via Polygon.io
Prokidney Corp.: frequently asked questions
Is Prokidney Corp. an American company?
Prokidney Corp. is a US-based company headquartered in Winston-Salem, North Carolina, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Prokidney Corp. headquartered?
Prokidney Corp. is headquartered in Winston-Salem, North Carolina, United States.
Is Prokidney Corp. publicly traded?
Yes — Prokidney Corp. is a publicly traded company. Its stock trades under the ticker symbol PROK on the NASDAQ.
What does Prokidney Corp. do?
Prokidney Corp. is an American Pharmaceuticals company in the Health & Beauty sector.
